Navigation Links
Markel Reports Third Quarter and Nine-Month Results
Date:11/4/2008

RICHMOND, Va., Nov. 4 /PRNewswire-FirstCall/ -- Markel Corporation (NYSE: MKL) reported diluted net loss per share of $14.46 for the quarter ended September 30, 2008 compared to diluted net income per share of $9.26 for the third quarter of 2007. Diluted net loss per share was $2.63 for the nine months ended September 30, 2008 compared to diluted net income per share of $31.28 for the same period of 2007. The results for both periods of 2008 reflect lower investment returns and less favorable underwriting results compared to the same periods of 2007.

Alan I. Kirshner, Chairman and Chief Executive Officer, commented, "Our third quarter and year-to-date results have been negatively impacted by the ongoing financial market turmoil, difficult underwriting conditions and recent hurricane activity. Our financial strength provides a solid foundation for us to capitalize on growth opportunities presented by today's marketplace. We are continuing to emphasize our underwriting standards and are increasing prices for many of our products in response to market conditions."

The combined ratio for the third quarter of 2008 was 124% compared to 87% for the third quarter of 2007. The combined ratio for the nine months ended September 30, 2008 was 104% compared to 88% for the same period of 2007. The combined ratio for the quarter and nine months ended September 30, 2008 included $115.1 million, or 22 points and 8 points, respectively, of underwriting loss related to Hurricanes Gustav and Ike.

Net realized investment losses for the quarter and nine months ended September 30, 2008 were $168.7 million and $200.2 million, respectively, compared to net realized investment gains of $3.0 million and $64.7 million, respectively, for the quarter and nine months ended September 30, 2007. Net realized investment losses include both losses from the sale of securities and losses classified as other-than-temporarily impaired. Net realized investment losses for the third quarter and nine months ended September 30, 2008 included $94.6 million and $187.1 million, respectively, of write downs for other-than-temporary declines in the estimated fair value of investments.

During the quarter and nine months ended September 30, 2008, the Company's pre-tax net unrealized investment gains decreased $19.8 million and $374.6 million, respectively. For the quarter and nine months ended September 30, 2008, the aggregate of net realized investment losses and the decrease in pre-tax net unrealized investment gains totaled $188.5 million and $574.8 million, respectively. The aggregate unfavorable movement in the value of the Company's investment portfolio during the third quarter of 2008 represented approximately 3% of the Company's average invested assets for the quarter, while the aggregate year-to-date unfavorable movement represented approximately 8% of the Company's average invested assets for the year.

Book value per common share outstanding decreased 11% to $235.72 at September 30, 2008 from $265.26 at December 31, 2007. The decline in book value was primarily due to a decline in the market value of the Company's investment portfolio and underwriting losses for the nine months ended September 30, 2008.

Losses from Hurricanes Gustav and Ike and the aggregate of net realized investment losses and pre-tax decrease in net unrealized investment gains were in line with the Company's estimates included in its press release on October 9, 2008. However, net realized investment losses for the third quarter of 2008 increased from the Company's preliminary estimate of $116 million. The increase in net realized investment losses was related to equity securities, principally General Electric Company and International Game Technology, that were deemed to have other-than-temporary declines in estimated fair value. This determination was made in conjunction with the completion of the Company's quarterly review of its investment portfolio for other-than-temporary impairment and reflects a more in-depth analysis of the financial condition and near-term prospects of these two issuers. The losses associated with these equity securities were initially included in the Company's preliminary estimate of the decrease in net unrealized investment gains, net of taxes, at September 30, 2008. As a result, the Company's preliminary estimate of aggregate net realized investment losses and decreases in pre-tax net unrealized investment gains was unchanged.

The Company also announced today it has filed its Form 10-Q for the quarter ended September 30, 2008 with the Securities and Exchange Commission. A copy of the Form 10-Q is available on the Company's website at http://www.markelcorp.com or on the SEC website at http://www.sec.gov. Readers are urged to review the Form 10-Q for a more complete discussion of the Company's financial performance. The Company's quarterly conference call, which will involve discussion of the Company's financial results and business developments and may include forward-looking information, will be held Wednesday, November 5, 2008, beginning at 10:30 a.m. (Eastern Standard Time). Any person interested in listening to the call, or a replay of the call, which will be available from approximately two hours after the conclusion of the call until Saturday, November 15, 2008, should contact Markel's Investor Relations Department at 804-747-0136. Investors, analysts and the general public also may listen to the call free over the Internet through the Company's web site, http://www.markelcorp.com.

Markel Corporation markets and underwrites specialty insurance products and programs to a variety of niche markets. In each of these markets, the Company seeks to provide quality products and excellent customer service so that it can be a market leader. The financial goals of the Company are to earn consistent underwriting profits and superior investment returns to build shareholder value.


'/>"/>
SOURCE Markel Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Markel Expands Classes for Contagion Risk with OUTBREAK(R) Extra Expense Coverage
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. Haemacure Reports Third Quarter 2007 Results
4. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
5. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
6. MDS Reports Third Quarter 2007 Results
7. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
8. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
9. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
10. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
11. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 26, 2017 , ... Mediaplanet is proud to announce the launch of its ... will educate readers on how to take care of all aspects of their skin. ... on melanoma. Dancing with the Stars professional, Witney Carson, shares her journey with the ...
(Date:5/26/2017)... ... May 26, 2017 , ... The American ... review more than eighty-nine grant submissions all vying for nearly $1,000,000 in funding ... Parkinson’s field.     , The American Parkinson Disease Association (APDA) is focused on advancing ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... Boston CEO 2017 on May 30th and 31st at The Four Seasons Hotel ... leading executives in the life sciences, offering exclusive access to key decision makers ...
(Date:5/26/2017)... ... May 26, 2017 , ... The ... educational seminar to focus on current legislative activity and the latest regulatory concerns ... 1 p.m. Sunday, Sept. 10, and will continue through Monday, Sept. 11, at ...
(Date:5/26/2017)... ... 26, 2017 , ... Amir Qureshi, MD is the first physician in Arkansas ... stimulation system. The Nuvectra™ Algovita SCS System has been FDA approved as a treatment ... in Arkansas to introduce the most powerful SCS system and the only stretchable lead ...
Breaking Medicine News(10 mins):
(Date:5/26/2017)... May 26, 2017  Endo International plc (NASDAQ: ... and CEO, will represent the Company in a fireside chat ... on Tuesday, June 13, 2017 at 10:40 a.m. PT / ... Resort in Rancho Palos Verdes, CA. ... event will be available on the Company,s website at ...
(Date:5/26/2017)... 2017  In response to the opioid epidemic in ... is working with Pfizer to make up to 1 ... to community health centers, free and charitable clinics, public ... "Pfizer has a long-standing commitment to improving health ... safety through educational activities," said Caroline Roan , ...
(Date:5/24/2017)... 24, 2017  ivWatch LLC today announced the ... Board to enable seamless integration of ivWatch,s groundbreaking ... infusion pumps and other devices. By integrating ivWatch ... to help health care customers deliver a higher ... to IV therapy. "The ivWatch OEM ...
Breaking Medicine Technology: